跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 185,493 条关于
“von Hippel-Lindau disease”
全部
185,493
临床试验
160,956
药物
1,774
机构
253
资讯
22,510
去年
Belzutifan Shows Sustained Efficacy in VHL-Associated CNS Hemangioblastomas
去年
Pharmaceutical Giants Pfizer, Merck, and AbbVie Lead Innovation Against Global Diseases
去年
Arcus's HIF-2α Inhibitor Shows Promise in Kidney Cancer, Despite Gilead's Exit
去年
FDA Grants Priority Review to Belzutifan for Advanced Pheochromocytoma and Paraganglioma
去年
Canada Expands Access to Rare Disease Medications Through Provincial Agreements
2年前
FDA Approves Merck's Welireg for Advanced Kidney Cancer, Expanding Treatment Options
9个月前
Canada's $1.5 Billion Rare Disease Strategy Shows Early Success with Nine Life-Saving Treatments
10个月前
Merck-Eisai Kidney Cancer Combination Shows Mixed Results in Phase 3 Trial
去年
China Approves MSD's Welireg (belzutifan) for VHL-Associated Tumors
去年
China Approves MSD's Welireg (belzutifan) for VHL Disease-Associated Tumors
第 1 页，共 2251 页
上一页
下一页
